First Time Loading...

Natus Medical Inc
NASDAQ:NTUS

Watchlist Manager
Natus Medical Inc Logo
Natus Medical Inc
NASDAQ:NTUS
Watchlist
Price: 32.96 USD Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

NTUS Price Targets Summary
Natus Medical Inc

There are no price targets for NTUS.
NTUS Lowest Forecast
Wall Street Target
Not Available
NTUS Average Forecast
Wall Street Target
Not Available
NTUS Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Natus Medical Inc Competitors:
Price Targets
AXGN
AxoGen Inc
141% Upside
MEDI
Medistim ASA
10% Upside
ECOR
electroCore, Inc.
273% Upside
ELN
El En SpA
6% Upside
AXGN
AxoGen Inc
141% Upside
MEDI
Medistim ASA
10% Upside
ECOR
electroCore, Inc.
273% Upside
ELN
El En SpA
6% Upside
IDXX
IDEXX Laboratories Inc
28% Upside
LMAT
LeMaitre Vascular Inc
2% Downside
H
HYPR
Hyperfine Inc
66% Upside
300562
Guangdong Transtek Medical Electronics Co Ltd
48% Upside

Revenue
Forecast

Revenue Estimate
Natus Medical Inc

For the last 8 years the compound annual growth rate for Natus Medical Inc's revenue is 4%. The projected CAGR for the next 2 years is 5%.

4%
Past Growth
5%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Natus Medical Inc

Operating Income forecast
is not available for
Natus Medical Inc

Net Income
Forecast

Net Income Estimate
Natus Medical Inc

For the last 8 years the compound annual growth rate for Natus Medical Inc's net income is -7%. The projected CAGR for the next 2 years is 103%.

-7%
Past Growth
103%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
NTUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NTUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NTUS stock valuation using valuation multiples.
Wall Street Estimates
NTUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NTUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NTUS's stock price target?
Not Available

NTUS doesn't have any price targets made by Wall Street professionals.

What is Natus Medical Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Natus Medical Inc's revenue is 4%. The projected CAGR for the next 2 years is 5%.

What is Natus Medical Inc's Net Income forecast?
Projected CAGR
103%

For the last 8 years the compound annual growth rate for Natus Medical Inc's net income is -7%. The projected CAGR for the next 2 years is 103%.

ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.